These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11079015)

  • 21. Evaluation of genome-wide loci of iron metabolism in hereditary hemochromatosis identifies PCSK7 as a host risk factor of liver cirrhosis.
    Stickel F; Buch S; Zoller H; Hultcrantz R; Gallati S; Österreicher C; Finkenstedt A; Stadlmayr A; Aigner E; Sahinbegovic E; Sarrazin C; Schafmayer C; Braun F; Erhart W; Nothnagel M; Lerch MM; Mayerle J; Völzke H; Schaller A; Kratzer W; Boehm BO; Sipos B; D'Amato M; Torkvist L; Stal P; Arlt A; Franke A; Becker T; Krawczak M; Zwerina J; Berg T; Hinrichsen H; Krones E; Dejaco C; Strasser M; Datz C; Hampe J
    Hum Mol Genet; 2014 Jul; 23(14):3883-90. PubMed ID: 24556216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iron in nonhemochromatotic liver disorders.
    Alla V; Bonkovsky HL
    Semin Liver Dis; 2005 Nov; 25(4):461-72. PubMed ID: 16315139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C.
    Bonkovsky HL; Naishadham D; Lambrecht RW; Chung RT; Hoefs JC; Nash SR; Rogers TE; Banner BF; Sterling RK; Donovan JA; Fontana RJ; Di Bisceglie AM; Ghany MG; Morishima C;
    Gastroenterology; 2006 Nov; 131(5):1440-51. PubMed ID: 17101320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations and relationship with hepatic histological lesions.
    Hézode C; Cazeneuve C; Coué O; Roudot-Thoraval F; Lonjon I; Bastie A; Duvoux C; Pawlotsky JM; Zafrani ES; Amselem S; Dhumeaux D
    J Hepatol; 1999 Dec; 31(6):979-84. PubMed ID: 10604569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases.
    Sham RL; Ou CY; Cappuccio J; Braggins C; Dunnigan K; Phatak PD
    Blood Cells Mol Dis; 1997 Aug; 23(2):314-20. PubMed ID: 9410475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Molecular genetic diagnostics and screening of hereditary hemochromatosis].
    Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S
    Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of the C282Y mutation of the hemochromatosis gene in liver transplant recipients and donors.
    Alanen KW; Chakrabarti S; Rawlins JJ; Howson W; Jeffrey G; Adams PC
    Hepatology; 1999 Sep; 30(3):665-9. PubMed ID: 10462372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HFE based re-evaluation of heterozygous hemochromatosis.
    Moirand R; Guyader D; Mendler MH; Jouanolle AM; Le Gall JY; David V; Brissot P; Deugnier Y
    Am J Med Genet; 2002 Sep; 111(4):356-61. PubMed ID: 12210292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.
    Valenti L; Fracanzani AL; Bugianesi E; Dongiovanni P; Galmozzi E; Vanni E; Canavesi E; Lattuada E; Roviaro G; Marchesini G; Fargion S
    Gastroenterology; 2010 Mar; 138(3):905-12. PubMed ID: 19931264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterozygosity for the hemochromatosis gene in liver diseases--prevalence and effects on liver histology.
    Höhler T; Leininger S; Köhler HH; Schirmacher P; Galle PR
    Liver; 2000 Dec; 20(6):482-6. PubMed ID: 11169063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of association between HFE gene mutations and hepatocellular carcinoma in patients with cirrhosis.
    Boige V; Castéra L; de Roux N; Ganne-Carrié N; Ducot B; Pelletier G; Beaugrand M; Buffet C
    Gut; 2003 Aug; 52(8):1178-81. PubMed ID: 12865278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iron overload in cirrhosis-HFE genotypes and outcome after liver transplantation.
    Brandhagen DJ; Alvarez W; Therneau TM; Kruckeberg KE; Thibodeau SN; Ludwig J; Porayko MK
    Hepatology; 2000 Feb; 31(2):456-60. PubMed ID: 10655270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C.
    Bonkovsky HL; Troy N; McNeal K; Banner BF; Sharma A; Obando J; Mehta S; Koff RS; Liu Q; Hsieh CC
    J Hepatol; 2002 Dec; 37(6):848-54. PubMed ID: 12445428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histological evaluation of iron in liver biopsies: relationship to HFE mutations.
    Brunt EM; Olynyk JK; Britton RS; Janney CG; Di Bisceglie AM; Bacon BR
    Am J Gastroenterol; 2000 Jul; 95(7):1788-93. PubMed ID: 10925986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hereditary and acquired iron overload].
    de Korwin JD
    Nephrol Ther; 2006 Nov; 2 Suppl 5():S304-12. PubMed ID: 17373275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The C282Y mutation in the haemochromatosis gene (HFE) and hepatitis C virus infection are independent cofactors for porphyria cutanea tarda in Australian patients.
    Stuart KA; Busfield F; Jazwinska EC; Gibson P; Butterworth LA; Cooksley WG; Powell LW; Crawford DH
    J Hepatol; 1998 Mar; 28(3):404-9. PubMed ID: 9551677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is there a threshold of hepatic iron concentration that leads to cirrhosis in C282Y hemochromatosis?
    Adams PC
    Am J Gastroenterol; 2001 Feb; 96(2):567-9. PubMed ID: 11232708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A genotypic study of 217 unrelated probands diagnosed as "genetic hemochromatosis" on "classical" phenotypic criteria.
    Brissot P; Moirand R; Jouanolle AM; Guyader D; Le Gall JY; Deugnier Y; David V
    J Hepatol; 1999 Apr; 30(4):588-93. PubMed ID: 10207799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Could iron deposits in hepatocytes serve as a prognostic marker of HFE gene mutations?
    Sikorska K; Stalke P; Jaskiewicz K; Romanowski T; Bielawski KP
    Hepatogastroenterology; 2008; 55(84):1024-8. PubMed ID: 18705322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver pathology in compound heterozygous patients for hemochromatosis mutations.
    Schöniger-Hekele M; Müller C; Polli C; Wrba F; Penner E; Ferenci P
    Liver; 2002 Aug; 22(4):295-301. PubMed ID: 12296962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.